Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More
Luminex Licensed Technologies Partner Spotlight: Bio-Techne
Helping users make the switch from single-analyte ELISAs to multiplexing
For scientists who are new to multiplexing, Bio-Techne is a great place to start. This well-known ELISA kit manufacturer makes it easy for users to make the transition from manual, single-analyte ELISAs to robust multiplex testing with xMAP® Technology. In this partner spotlight, we spoke with Liz Cremer, immunoassay instrument specialist at Bio-Techne, to learn more about how Bio-Techne uses xMAP to solve customer challenges.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results
October 18
Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio
October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018
September 11
Luminex Corporation Declares Third Quarter Cash Dividend
September 6
Luminex Corporation to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
xMAP® Connect Amsterdam
6-7 November
Amsterdam, Netherlands
